Sarcopenia in daily practice: assessment and management.
Sarcopenia in daily practice: assessment and management.
复制标题
DOI：
10.1186/s12877-016-0349-4
复制
发表时间：
2016-10-05
期刊：
影响因子：
4.1
通讯作者：
Cooper C
中科院分区：
文献类型：
--
作者：
Beaudart C;McCloskey E;Bruyère O;Cesari M;Rolland Y;Rizzoli R;Araujo de Carvalho I;Amuthavalli Thiyagarajan J;Bautmans I;Bertière MC;Brandi ML;Al-Daghri NM;Burlet N;Cavalier E;Cerreta F;Cherubini A;Fielding R;Gielen E;Landi F;Petermans J;Reginster JY;Visser M;Kanis J;Cooper C
肌肉减少症越来越多地被认为是衰老的相关因素，并与不良结局（包括福尔斯、骨折、虚弱和死亡）的可能性增加相关。已经推荐了几种工具来评估临床试验中的肌肉质量、肌肉力量和身体表现。虽然这些工具已被证明是准确和可靠的研究设置，许多不容易应用于日常实践。本文基于欧洲骨质疏松症和骨关节炎临床和经济方面学会（ESCEO）虚弱和肌肉减少症工作组成员进行的文献综述。随后，为整个小组组织了面对面的会议，以提出修正案并讨论进一步的建议。本文提出了一些用户友好和廉价的方法，可用于评估肌肉减少症在现实生活中的设置。医疗保健提供者，特别是在初级保健中，应考虑评估风险增加的个体的肌肉减少症;建议用于评估风险的工具包括红旗方法，SARC-F问卷，SMI方法或不同的预测方程。肌肉减少症的管理应主要以患者为中心，并涉及基于抵抗力和耐力的活动计划的组合，有或没有饮食干预。一些药物干预措施的开发也在进行中。在不久的将来，评估具有风险因素、症状和/或使其暴露于残疾风险的状况的个体的肌肉减少症将变得特别重要。
Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice. This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations. This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress. Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future.
登录
查看更多内容
影响因子：
3.9
作者：
Beaudart, C.;Reginster, J. Y.;Bruyere, O.
通讯作者：
Bruyere, O.
DOI：
10.1093/gerona/55.6.m350
发表时间：
2000-06-01
影响因子：
5.1
作者：
Brown, M;Sinacore, DR;Kohrt, WM
通讯作者：
Kohrt, WM
影响因子：
2.8
作者：
Arden N;Richette P;Cooper C;Bruyère O;Abadie E;Branco J;Brandi ML;Berenbaum F;Clerc C;Dennison E;Devogelaer JP;Hochberg M;D'Hooghe P;Herrero-Beaumont G;Kanis JA;Laslop A;Leblanc V;Maggi S;Mautone G;Pelletier JP;Petit-Dop F;Reiter-Niesert S;Rizzoli R;Rovati L;Tajana Messi E;Tsouderos Y;Martel-Pelletier J;Reginster JY
通讯作者：
Reginster JY
影响因子：
3.6
作者：
Denison HJ;Cooper C;Sayer AA;Robinson SM
通讯作者：
Robinson SM
影响因子：
3.4
作者：
Bohannon, Richard W.;Magasi, Susan R.;Bubela, Deborah J.;Wang, Ying-Chih;Gershon, Richard C.
通讯作者：
Gershon, Richard C.